England sees increase in influenza hospitalisations
According to statistics from the National 'Flu and Covid-19 Surveillance Report published by the UK's National Health Service (NHS) on…
Analyst Comment
FDA approves Lerochol as monthly PCSK9 inhibitor for hypercholesterolemia
ASH 2025: J&J’s Tecvayli + Darzalex set to redefine early relapsed MM
ASH 2025: AbbVie and Genmab’s Epkinly sets new standard in second-line FL
ASH 2025: Eli Lilly’s Jaypirca emerges as a strong first-line contender in CLL/SLL
Brazilian study links postnatal rapid weight gain to elevated paediatric BMI
New HBV vaccine guidance likely to increase infection among newborns
ASH 2025: potential new BCL2 inhibitor option for R/R CLL
